July 14, 2021

GenomOncology announced that ARUP has chosen to extend its use of the GenomOncology (GO) Precision Oncology API Suite by integrating the GO Clinical Trial and Therapy Matching APIs into its workflows.

July 1, 2021


Adam Barker, PhD, has been appointed as ARUP’s chief scientific officer, a role in which he will lead the newly formed New Technologies Group.

June 30, 2021


ARUP Laboratories today bid farewell to CEO Sherrie L. Perkins, MD, PhD, who retired after 31 years with the company and the University of Utah Department of Pathology.

June 18, 2021

ARUP announced that it has received the 2021 Supplier Legacy Award from Premier Inc., a leading healthcare improvement company.